glp-1 muscle mass loss Study finds receptor agonists target fat over for weight Weight loss with GLP-1 medicines

Its growing cardiovascular-outcomes evidence, combined with expanding reimbursement and manufacturing capacity, positions it to capture an estimated 44% share of global obesity GLP-1 sales by 2035

Both GIP and GLP-1 play roles in regulating food intake by stimulating neurons in the brains satiety center

This action leads to weight loss by promoting satiety, which means patients feel fuller for longer periods and are less likely to overeat

Data Availability Statement The data supporting the findings of this study are available on the websites mentioned in the References section.

Wang Y, Dilidaxi D, Wu Y, Sailike J, Sun X, Nabi X-H